104.33
0.01%
0.10
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $104.33, with a volume of 4.39M.
It is up +0.01% in the last 24 hours and down -8.32% over the past month.
See More
Previous Close:
$104.23
Open:
$104.315
24h Volume:
4.39M
Relative Volume:
0.48
Market Cap:
$285.14B
Revenue:
$62.48B
Net Income/Loss:
$13.74B
P/E Ratio:
57.96
EPS:
1.8
Net Cash Flow:
$13.15B
1W Performance:
-2.25%
1M Performance:
-8.32%
6M Performance:
-19.89%
1Y Performance:
+1.38%
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Merck Co Inc Stock (MRK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
Nov-09-23 | Initiated | Deutsche Bank | Buy |
Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Oct-20-23 | Upgrade | UBS | Neutral → Buy |
Jul-14-23 | Initiated | HSBC Securities | Hold |
Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Mar-06-23 | Initiated | Jefferies | Buy |
Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
Nov-18-22 | Initiated | Credit Suisse | Outperform |
Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
Jun-06-22 | Resumed | SVB Leerink | Outperform |
Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
Dec-17-21 | Initiated | Goldman | Buy |
Dec-16-21 | Initiated | Daiwa Securities | Neutral |
Dec-13-21 | Downgrade | UBS | Buy → Neutral |
Dec-09-21 | Initiated | Wells Fargo | Overweight |
Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
Nov-01-21 | Upgrade | Argus | Hold → Buy |
Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-27-21 | Resumed | Truist | Buy |
May-20-21 | Downgrade | Argus | Buy → Hold |
Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
Nov-10-20 | Resumed | Bernstein | Outperform |
Sep-29-20 | Initiated | Berenberg | Hold |
Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Feb-27-20 | Initiated | Barclays | Overweight |
Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
Oct-17-19 | Resumed | BofA/Merrill | Neutral |
Aug-16-19 | Initiated | SVB Leerink | Outperform |
Jul-03-19 | Initiated | Mizuho | Buy |
May-28-19 | Initiated | Goldman | Neutral |
May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
Oct-16-18 | Reiterated | Citigroup | Buy |
Oct-09-18 | Resumed | Guggenheim | Buy |
Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Orrstown Financial Services Inc. - MarketBeat
Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.2%What's Next? - MarketBeat
Why Is Moderna Stock Trading Higher On Monday? - Benzinga
Merck: collaboration with Moderna in lung cancer - Marketscreener.com
Riggs Asset Managment Co. Inc. Decreases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Global Lung Cancer Therapeutics Market Set to Reach USD 48,725.9 Million by 2026 with an Impressive CAGR of 13.4% growth over the forecast period 2022 to 2032 | FMI - GlobeNewswire Inc.
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Allworth Financial LP - MarketBeat
Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024 - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Boston Trust Walden Corp - MarketBeat
Is Merck Stock Undervalued After Its Colossal Earnings Growth? - MSN
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL) - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) PT Lowered to $130.00 - MarketBeat
Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat (MRK) - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.4%What's Next? - MarketBeat
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.
International Assets Investment Management LLC Has $337.45 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Arcus Begins Differentiating Its HIF-2a inhibitor Versus Merck’s Welireg - Scrip
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.2%Time to Sell? - MarketBeat
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines - Benzinga
Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance - Insider Monkey
Assenagon Asset Management S.A. Buys 805,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Modifi acquired by Merck in $1.3B deal - BioWorld Online
Merck: EU approves two new indications for Keytruda - Marketscreener.com
Merck acquires cancer therapeutics maker Modifi for $1.3bn - World Pharmaceutical Frontiers
Merck & Co., Inc. (MRK) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Pfizer, Merck Pneumonia Shots Get Backing for Adults Over 50 - Bloomberg
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck Animal Health introduces SENSEHUB Dairy Youngstock - High Plains Journal
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 bln - Reuters
Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts? - Insider Monkey
Merck Buys Yale Cancer-Therapy Spinout Modifi Biosciences - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Private Advisor Group LLC - MarketBeat
Modifi Biosciences Acquired by Merck - GlobeNewswire
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Cold Sore Treatment Market Expected to Hit USD 1.57 Bn by 2031, With an 6.3% CAGR |Merck & Co Inc, Pfizer Inc, - EIN News
Q3 EPS Estimates for Merck & Co., Inc. Cut by Zacks Research - MarketBeat
The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Vest Financial LLC - MarketBeat
Top Research Reports for Visa, Netflix & Merck - Yahoo Finance
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold? - Nasdaq
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks - Yahoo Finance
Corundum Group Inc. Sells 6,325 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Non Muscle Invasive Bladder Cancer Market Breaking New Ground | Merck & Co., Inc., Ferring Pharmaceuticals, - EIN News
Merck: presents results of HIV study - Marketscreener.com
Merck & Co. Inc. (MRK): Among the Best US Stocks for Foreign Investors Right Now - Insider Monkey
Creative Planning Has $95.67 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):